Selecting Technologies that Support you from Clinical to Commercial Manufacturing
19 Jan 2023
08:00
Briefing 1
SPONSORED BY
Points for discussion
As cell therapy developers scale their manufacturing operations, technology choices become forefront. Selecting the right technologies to manufacture cell therapies has resourcing, cost, and efficiency implications that need to be considered
- Evaluation criteria for choosing between turnkey and custom manufacturing solutions, with particular focus on fit, function, and format
- What do manufacturing expectations look like and how do they change through process development, clinical development and scaling to meet anticipated demand post-approval
- The benefits and roadblocks to using equipment that can transition from PD to GMP
Agenda
8am Panel
8:50am Q&A
Moderator:
David Hodl, Head of Sales, Cell Therapy Custom and Configured Platforms, Invetech
Speakers
Priya Baraniak, Vice President Corporate Development & Head Product Development, OrganaBio
Fernanda Masri, Head of Manufacturing Innovation, Cell & Gene Therapy Catapult
Fabio Fachin, Head of Cell Therapy Process Development, Takeda
Speakers
